Lianluo Smart (NASDAQ:LLIT) vs. Mazor Robotics (MZOR) Financial Comparison

Lianluo Smart (NASDAQ:LLIT) and Mazor Robotics (NASDAQ:MZOR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and valuation.

Risk & Volatility

Lianluo Smart has a beta of 1.85, meaning that its share price is 85% more volatile than the S&P 500. Comparatively, Mazor Robotics has a beta of 1.39, meaning that its share price is 39% more volatile than the S&P 500.

Earnings & Valuation

This table compares Lianluo Smart and Mazor Robotics’ gross revenue, earnings per share and valuation.

Lianluo Smart has higher earnings, but lower revenue than Mazor Robotics.

Profitability

This table compares Lianluo Smart and Mazor Robotics’ net margins, return on equity and return on assets.

Insider & Institutional Ownership

0.8% of Lianluo Smart shares are owned by institutional investors. Comparatively, 32.7% of Mazor Robotics shares are owned by institutional investors. 22.9% of Lianluo Smart shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Lianluo Smart and Mazor Robotics, as reported by MarketBeat.com.

Mazor Robotics has a consensus target price of $59.50, indicating a potential upside of 2.18%. Given Mazor Robotics’ higher possible upside, analysts plainly believe Mazor Robotics is more favorable than Lianluo Smart.

Summary

Lianluo Smart beats Mazor Robotics on 7 of the 10 factors compared between the two stocks.

About Lianluo Smart

Lianluo Smart Limited, through its subsidiaries, designs, develops, markets, and distributes medical products and medical components primarily in the People’s Republic of China. The company offers medical devices, including sleep apnea diagnostic products, general hospital products, medical compressors, and related supporting products, such as laryngoscope. It also distributes medical products designed and manufactured by other companies. The company sells its products primarily through distributors; and directly to hospital, physical examination centers, and governmental agencies, as well as to individuals. The company was formerly known as Dehaier Medical Systems Limited and changed its name to Lianluo Smart Limited in November 2016. Lianluo Smart Limited was founded in 2003 and is headquartered in Beijing, the People’s Republic of China. Lianluo Smart Limited operates as a subsidiary of Hangzhou Liaison Interactive Information Technology Co., Ltd.

About Mazor Robotics

Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures. The company’s surgical robotic-guidance systems and complementary products are used to conduct spine and brain procedures in an accurate and secure manner. It also offers Mazor X, a renaissance system and its accessories are used in spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision, and cement augmentations. The company was formerly known as Mazor Surgical Technologies Ltd. and changed its name to Mazor Robotics Ltd. in 2010. Mazor Robotics Ltd. was founded in 2000 and is based in Caesarea, Israel.

Receive News & Ratings for Lianluo Smart Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Lianluo Smart and related companies with MarketBeat.com’s FREE daily email newsletter.